List of Tables
Table 1. Human Immune Globulin Intravenous Market Trends
Table 2. Human Immune Globulin Intravenous Market Drivers & Opportunity
Table 3. Human Immune Globulin Intravenous Market Challenges
Table 4. Human Immune Globulin Intravenous Market Restraints
Table 5. Global Human Immune Globulin Intravenous Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Human Immune Globulin Intravenous Revenue Market Share by Company (2019-2024)
Table 7. Global Human Immune Globulin Intravenous Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Human Immune Globulin Intravenous Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Human Immune Globulin Intravenous Price by Company (2019-2024) & (USD/Unit)
Table 10. Key Manufacturers Human Immune Globulin Intravenous Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Human Immune Globulin Intravenous Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Human Immune Globulin Intravenous
Table 13. Global Human Immune Globulin Intravenous Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Immune Globulin Intravenous as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Immune Globulin Intravenous Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Human Immune Globulin Intravenous Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Human Immune Globulin Intravenous Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Human Immune Globulin Intravenous Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Human Immune Globulin Intravenous Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Human Immune Globulin Intravenous Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Human Immune Globulin Intravenous Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Human Immune Globulin Intravenous Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Human Immune Globulin Intravenous Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Human Immune Globulin Intravenous Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Human Immune Globulin Intravenous Price by Type (2019-2024) & (USD/Unit)
Table 27. Global Human Immune Globulin Intravenous Price by Type (2025-2030) & (USD/Unit)
Table 28. Global Human Immune Globulin Intravenous Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Human Immune Globulin Intravenous Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Human Immune Globulin Intravenous Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Human Immune Globulin Intravenous Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Human Immune Globulin Intravenous Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Human Immune Globulin Intravenous Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Human Immune Globulin Intravenous Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Human Immune Globulin Intravenous Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Human Immune Globulin Intravenous Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Human Immune Globulin Intravenous Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Human Immune Globulin Intravenous Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Human Immune Globulin Intravenous Price by Application (2025-2030) & (USD/Unit)
Table 40. Global Human Immune Globulin Intravenous Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Human Immune Globulin Intravenous Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Human Immune Globulin Intravenous Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Human Immune Globulin Intravenous Sales Value by Region (2019-2024) & (%)
Table 44. Global Human Immune Globulin Intravenous Sales Value by Region (2025-2030) & (%)
Table 45. Global Human Immune Globulin Intravenous Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Human Immune Globulin Intravenous Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Human Immune Globulin Intravenous Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Human Immune Globulin Intravenous Sales Volume by Region (2019-2024) & (%)
Table 49. Global Human Immune Globulin Intravenous Sales Volume by Region (2025-2030) & (%)
Table 50. Global Human Immune Globulin Intravenous Average Price by Region (2019-2024) & (USD/Unit)
Table 51. Global Human Immune Globulin Intravenous Average Price by Region (2025-2030) & (USD/Unit)
Table 52. Key Countries/Regions Human Immune Globulin Intravenous Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Human Immune Globulin Intravenous Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Human Immune Globulin Intravenous Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Human Immune Globulin Intravenous Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Human Immune Globulin Intravenous Sales Volume, (2025-2030) & (K Units)
Table 57. Takeda Company Information
Table 58. Takeda Introduction and Business Overview
Table 59. Takeda Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 60. Takeda Human Immune Globulin Intravenous Product Offerings
Table 61. Takeda Recent Development
Table 62. Grifols Company Information
Table 63. Grifols Introduction and Business Overview
Table 64. Grifols Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 65. Grifols Human Immune Globulin Intravenous Product Offerings
Table 66. Grifols Recent Development
Table 67. CSL Company Information
Table 68. CSL Introduction and Business Overview
Table 69. CSL Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 70. CSL Human Immune Globulin Intravenous Product Offerings
Table 71. CSL Recent Development
Table 72. Octapharma Company Information
Table 73. Octapharma Introduction and Business Overview
Table 74. Octapharma Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 75. Octapharma Human Immune Globulin Intravenous Product Offerings
Table 76. Octapharma Recent Development
Table 77. Biotest Company Information
Table 78. Biotest Introduction and Business Overview
Table 79. Biotest Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 80. Biotest Human Immune Globulin Intravenous Product Offerings
Table 81. Biotest Recent Development
Table 82. Kedrion Company Information
Table 83. Kedrion Introduction and Business Overview
Table 84. Kedrion Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 85. Kedrion Human Immune Globulin Intravenous Product Offerings
Table 86. Kedrion Recent Development
Table 87. Hualan Bio Company Information
Table 88. Hualan Bio Introduction and Business Overview
Table 89. Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 90. Hualan Bio Human Immune Globulin Intravenous Product Offerings
Table 91. Hualan Bio Recent Development
Table 92. CNBG Company Information
Table 93. CNBG Introduction and Business Overview
Table 94. CNBG Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 95. CNBG Human Immune Globulin Intravenous Product Offerings
Table 96. CNBG Recent Development
Table 97. Shanghai RAAS Company Information
Table 98. Shanghai RAAS Introduction and Business Overview
Table 99. Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 100. Shanghai RAAS Human Immune Globulin Intravenous Product Offerings
Table 101. Shanghai RAAS Recent Development
Table 102. CBPO Company Information
Table 103. CBPO Introduction and Business Overview
Table 104. CBPO Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 105. CBPO Human Immune Globulin Intravenous Product Offerings
Table 106. CBPO Recent Development
Table 107. LFB Group Company Information
Table 108. LFB Group Introduction and Business Overview
Table 109. LFB Group Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 110. LFB Group Human Immune Globulin Intravenous Product Offerings
Table 111. LFB Group Recent Development
Table 112. BPL Company Information
Table 113. BPL Introduction and Business Overview
Table 114. BPL Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 115. BPL Human Immune Globulin Intravenous Product Offerings
Table 116. BPL Recent Development
Table 117. Sichuan Yuanda Shuyang Company Information
Table 118. Sichuan Yuanda Shuyang Introduction and Business Overview
Table 119. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 120. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Offerings
Table 121. Sichuan Yuanda Shuyang Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Human Immune Globulin Intravenous Downstream Customers
Table 125. Human Immune Globulin Intravenous Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Immune Globulin Intravenous Product Picture
Figure 2. Global Human Immune Globulin Intravenous Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Human Immune Globulin Intravenous Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Human Immune Globulin Intravenous Sales Volume (2019-2030) & (K Units)
Figure 5. Global Human Immune Globulin Intravenous Sales Price (2019-2030) & (USD/Unit)
Figure 6. Human Immune Globulin Intravenous Report Years Considered
Figure 7. Global Human Immune Globulin Intravenous Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Human Immune Globulin Intravenous Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Immune Globulin Intravenous Revenue in 2023
Figure 10. Human Immune Globulin Intravenous Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. IVIg Liquid Picture
Figure 12. IVIg Powder Picture
Figure 13. Global Human Immune Globulin Intravenous Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Human Immune Globulin Intravenous Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Human Immune Globulin Intravenous Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global Human Immune Globulin Intravenous Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Human Immune Globulin Intravenous Price by Type (2019-2030) & (USD/Unit)
Figure 18. Product Picture of Immunodeficiency
Figure 19. Product Picture of Autoimmune Disease
Figure 20. Product Picture of Acute Infection
Figure 21. Global Human Immune Globulin Intravenous Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Human Immune Globulin Intravenous Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Human Immune Globulin Intravenous Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Human Immune Globulin Intravenous Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Human Immune Globulin Intravenous Price by Application (2019-2030) & (USD/Unit)
Figure 26. North America Human Immune Globulin Intravenous Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Human Immune Globulin Intravenous Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Human Immune Globulin Intravenous Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Human Immune Globulin Intravenous Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Human Immune Globulin Intravenous Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Human Immune Globulin Intravenous Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Human Immune Globulin Intravenous Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Human Immune Globulin Intravenous Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Human Immune Globulin Intravenous Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Human Immune Globulin Intravenous Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Human Immune Globulin Intravenous Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Human Immune Globulin Intravenous Sales Volume (%), (2019-2030)
Figure 38. United States Human Immune Globulin Intravenous Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Human Immune Globulin Intravenous Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Human Immune Globulin Intravenous Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Human Immune Globulin Intravenous Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Human Immune Globulin Intravenous Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Human Immune Globulin Intravenous Sales Value by Application (%), 2023 VS 2030
Figure 44. China Human Immune Globulin Intravenous Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Human Immune Globulin Intravenous Sales Value by Type (%), 2023 VS 2030
Figure 46. China Human Immune Globulin Intravenous Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Human Immune Globulin Intravenous Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Human Immune Globulin Intravenous Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Human Immune Globulin Intravenous Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Human Immune Globulin Intravenous Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Human Immune Globulin Intravenous Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Human Immune Globulin Intravenous Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Human Immune Globulin Intravenous Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Human Immune Globulin Intravenous Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Human Immune Globulin Intravenous Sales Value by Application (%), 2023 VS 2030
Figure 56. India Human Immune Globulin Intravenous Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Human Immune Globulin Intravenous Sales Value by Type (%), 2023 VS 2030
Figure 58. India Human Immune Globulin Intravenous Sales Value by Application (%), 2023 VS 2030
Figure 59. Human Immune Globulin Intravenous Industrial Chain
Figure 60. Human Immune Globulin Intravenous Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
